ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

ARID3A promotes the development of colorectal cancer by upregulating AURKA

Tang, Jing; Yang, Lirui; Li, Yafei; Ning, Xuelian; Chaulagain, Anita; Wang, Tianzhen*; Wang, Dong*电子科技大学; 南方医科大学; 哈尔滨医科大学
Carcinogenesis2021-4DOI: 10.1093/carcin/bgaa118
19被引6阅读
引用收藏
分享

摘要

Colorectal cancer (CRC) is one of the most common malignant tumours, and its morbidity and mortality rates are relatively high. However, the aetiology and pathogenesis of CRC have not been clearly elucidated to date. AT-rich interaction domain 3A (ARID3A) is a member of the ARID3 family and a transcription factor that can bind to specific DNA sites to regulate gene expression. It was reported that ARID3A is involved in various biological processes and may be related to carcinogenesis. In this study, by assessing the mRNA level of ARID3A in TCGA database, we found that ARID3A expression increased in CRC tissues, and proposed that ARID3A could act as a tumour-promoting factor in the development of CRC. To verify this hypothesis, we used cell proliferation, migration and invasion assays to assess the effect of ARID3A on CRC cells. We revealed that ARID3A overexpression enhanced tumour cell proliferation, migration and invasion. ARID3A could target Aurora kinase A (AURKA) to facilitate the malignant phenotype of CRC cells, and patients with a higher ratio of AURKA and ARID3A had a better overall survival. Conclusively, this study showed that ARID3A targeted AURKA to facilitate the development of CRC. The ratio of ARID3A and AURKA could be used as a potential biomarker to predict prognosis, providing a new strategy for the diagnosis and prognosis of CRC.

学科与关键词

关键词
AURORA-A EXPRESSIONCELL-CYCLEKINASEFAMILYONCOGENEPROTEINS
相关
加载中…
  • ARID3A promotes the chemosensitivity of colon cancer by inhibiting AKR1C3
    Li, Yafei; Tang, Jing; Li, Jing; Du, Yaru; Bai, Fuqiang; Yang, Lirui; Li, Xiaobo; Jin, Xiaoming*; Wang, Tianzhen*CELL BIOLOGY INTERNATIONAL, 2022, 46(6): 965-975.被引 1
  • ARRB2 promotes colorectal cancer growth through triggering WTAP
    Liang, Hongguang; Lin, Zelong; Ye, Youqiong; Luo, Rongcheng*; Zeng, Lixian*ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2021, 53(1): 85-93.被引 9
  • Low expression of ZHX3 is associated with progression and poor prognosis in colorectal cancer
    Cai, Zhai*; Wang, Songsheng; Zhou, Huabin; Cao, DingTranslational Oncology, 2024, 39: 101829.
查看全部 →

发表信息

论文状态
公开发表
期刊
Carcinogenesis
发表日期
2021-04
卷期
第 42 卷, 第 4 期
页码
578-586
DOI
10.1093/carcin/bgaa118
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation of Heilongjiang Province [H2018009]

作者

  • T

    Tang, Jing (第一作者)

    southern med univ · harbin med univ

  • Y

    Yang, Lirui

    harbin med univ

查看全部 7 位作者收起作者
  • L

    Li, Yafei

    harbin med univ

  • N

    Ning, Xuelian

    harbin med univ

  • C

    Chaulagain, Anita

    harbin med univ

  • W

    Wang, Tianzhen (通讯)

    harbin med univ

  • W

    Wang, Dong (通讯)

    southern med univ · univ elect sci & technol china

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417